CRL Charles River Laboratories International, Inc. Stock Quote

CRL [NYSE]

Charles River Laboratories International, Inc.

Healthcare | Diagnostics & Research | USA

Index	-	P/E	38.77	EPS (ttm)	7.18	Insider Own	0.80%	Shs Outstand	49.75M	Perf Week	-3.45%
Market Cap	13.56B	Forward P/E	27.06	EPS next Y	10.28	Insider Trans	-28.45%	Shs Float	48.98M	Perf Month	4.61%
Income	364.30M	PEG	2.80	EPS next Q	2.18	Inst Own	96.00%	Short Float	1.35%	Perf Quarter	18.66%
Sales	2.92B	P/S	4.64	EPS this Y	41.90%	Inst Trans	0.02%	Short Ratio	2.09	Perf Half Y	27.09%
Book/sh	42.50	P/B	6.55	EPS next Y	12.32%	ROA	6.90%	Target Price	328.00	Perf Year	72.29%
Cash/sh	4.71	P/C	59.12	EPS next 5Y	13.87%	ROE	19.60%	52W Range	95.58 - 303.79	Perf YTD	11.37%
Dividend	-	P/FCF	35.69	EPS past 5Y	17.90%	ROI	8.60%	52W High	-8.40%	Beta	1.10
Dividend %	-	Quick Ratio	1.20	Sales past 5Y	16.50%	Gross Margin	36.70%	52W Low	191.14%	ATR	9.10
Employees	18400	Current Ratio	1.40	Sales Q/Q	14.50%	Oper. Margin	14.80%	RSI (14)	48.80	Volatility	2.83% 2.91%
Optionable	Yes	Debt/Eq	0.94	EPS Q/Q	73.20%	Profit Margin	12.50%	Rel Volume	0.91	Prev Close	287.46
Shortable	Yes	LT Debt/Eq	0.91	Earnings	Feb 17 BMO	Payout	0.00%	Avg Volume	315.74K	Price	278.27
Recom	1.90	SMA20	-1.84%	SMA50	2.97%	SMA200	23.15%	Volume	286,252	Change	-3.20%

Dec-16-20

Downgrade

Citigroup

Buy → Neutral

$270 → $250

Sep-10-20

Upgrade

Jefferies

Hold → Buy

$254

Jul-01-20

Upgrade

BofA Securities

Neutral → Buy

$192

May-13-20

Upgrade

UBS

Neutral → Buy

$177 → $200

Apr-21-20

Downgrade

Jefferies

Buy → Hold

$139

Mar-27-20

Upgrade

Morgan Stanley

Equal-Weight → Overweight

$152

Mar-02-20

Initiated

Deutsche Bank

Buy

$190

Feb-18-20

Upgrade

Wolfe Research

Peer Perform → Outperform

Jan-10-20

Upgrade

Goldman

Neutral → Buy

$143 → $179

Jan-08-20

Initiated

Wells Fargo

Overweight

$180

Jan-07-20

Initiated

Citigroup

Buy

$185

Oct-18-19

Downgrade

BofA/Merrill

Buy → Neutral

$150

Jun-10-19

Initiated

SVB Leerink

Outperform

$155

Apr-30-19

Resumed

Evercore ISI

Outperform

$160

Dec-14-18

Initiated

Deutsche Bank

Buy

Oct-09-18

Initiated

UBS

Neutral

Aug-23-18

Upgrade

Raymond James

Mkt Perform → Outperform

Jul-17-18

Upgrade

RBC Capital Mkts

Sector Perform → Outperform

Jun-15-18

Upgrade

KeyBanc Capital Mkts

Sector Weight → Overweight

Feb-14-18

Upgrade

SunTrust

Hold → Buy

Feb-25-21 08:00AM	Charles River Laboratories Announces Strategic Partnership with Kibur Medical to Advance Preclinical Oncology Studies Business Wire
Feb-24-21 05:20AM	Look for the Rally in Charles River Labs to Continue TheStreet.com
Feb-18-21 01:15PM	Charles River Labs International Shows Improved Relative Strength; Still Shy Of Benchmark Investor's Business Daily
08:52AM	A Look Into Charles River's Debt Benzinga
Feb-17-21 04:00PM	Charles River Laboratories International Inc (CRL) Q4 2020 Earnings Call Transcript Motley Fool
07:35AM	Charles River: Q4 Earnings Insights Benzinga
07:08AM	Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance Business Wire
07:06AM	Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development Business Wire
Feb-10-21 12:31PM	Charles River Laboratories (CRL) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Jan-29-21 12:10PM	Why Charles River (CRL) Could Beat Earnings Estimates Again Zacks
Jan-28-21 08:00AM	Charles River Announces Strategic Partnership with Cypre, Expanding 3D In Vitro Services for Cancer Immunotherapy and Targeted Therapy Drug Screening Business Wire
Jan-21-21 11:57PM	Estimating The Fair Value Of Charles River Laboratories International, Inc. (NYSE:CRL) Simply Wall St.
Jan-20-21 08:30AM	Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference Call Business Wire
Jan-15-21 12:57PM	Ariel Investments, Still Hopeful for Charles River Lab (CRL) to Continue Positive Momentum Insider Monkey
Jan-14-21 08:00AM	Charles River Partners with JADE Biomedical to Expand Biologics Capabilities Business Wire
Jan-11-21 08:00AM	Charles River Laboratories to Present at J.P. Morgan Healthcare Conference Business Wire
Jan-06-21 04:03PM	Charles River Labs Eyes 'SuperHuman' Gains As Breakout Nears Investor's Business Daily
Jan-04-21 07:00AM	Charles River Laboratories Acquires Distributed Bio Business Wire
Dec-25-20 02:44PM	Is CRL A Good Stock To Buy Now? Insider Monkey
Dec-23-20 12:34AM	If You Had Bought Charles River Laboratories International (NYSE:CRL) Stock Five Years Ago, You Could Pocket A 214% Gain Today Simply Wall St.
Dec-21-20 01:42AM	Toshiba Corporation -- Moody's withdraws Toshiba's B1 and Not Prime ratings for business reasons Moody's
Dec-16-20 12:16PM	Is Charles River Laboratories (CRL) a Smart Long-term Buy? Insider Monkey
Dec-09-20 08:00AM	Charles River Delivers Industry-First Deciphex Patholytix Digital Pathology Peer Review for GLP Studies Business Wire
Nov-27-20 12:43AM	Is Now An Opportune Moment To Examine Charles River Laboratories International, Inc. (NYSE:CRL)? Simply Wall St.
Nov-20-20 03:07PM	Charles River Laboratories Int'l, Inc. -- Moody's upgrades Charles River's CFR to Ba1; outlook stable Moody's
Nov-19-20 12:45PM	Charles River (CRL) is an Incredible Growth Stock: 3 Reasons Why Zacks
Nov-12-20 08:00AM	Charles River and PathoQuest Strengthen Strategic Partnership Business Wire
Nov-09-20 08:30AM	Charles River Laboratories to Present at Upcoming Investor Conferences Business Wire -5.35%
Nov-05-20 09:15AM	Charles River (CRL) Soars to 52-Week High, Time to Cash Out? Zacks
Nov-03-20 12:45PM	3 Reasons Growth Investors Will Love Charles River (CRL) Zacks
Nov-01-20 08:20AM	Earnings Beat: Charles River Laboratories International, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models Simply Wall St.
Oct-30-20 04:31AM	Charles River Laboratories International Inc (CRL) Q3 2020 Earnings Call Transcript Motley Fool
Oct-29-20 09:00PM	Toshiba Honored with Five Accolades at GOOD DESIGN AWARD 2020 PR Newswire
07:00AM	Charles River Laboratories Announces Third-Quarter 2020 Results Business Wire
Oct-28-20 12:26PM	Healthcare Stock Q3 Earnings Due on Oct 29: NVCR, CRL & More Zacks
Oct-27-20 06:03PM	Were Hedge Funds Right About Crowding Into Charles River Laboratories (CRL)? Insider Monkey
Oct-26-20 06:53AM	Does Charles River Laboratories International (NYSE:CRL) Deserve A Spot On Your Watchlist? Simply Wall St.
Oct-22-20 12:34PM	Charles River Laboratories (CRL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
12:10PM	Can Charles River (CRL) Keep the Earnings Surprise Streak Alive? Zacks
Oct-18-20 09:00PM	Toshiba launches Quantum Key Distribution (QKD) System Business PR Newswire
Oct-17-20 12:19AM	Toshiba Corporation -- Moody's announces completion of a periodic review of ratings of Toshiba Corporation Moody's
Oct-16-20 09:15AM	Charles River Laboratories Adds George Llado to Board of Directors Business Wire
Oct-13-20 08:30AM	Charles River Laboratories Schedules Third-Quarter 2020 Earnings Release and Conference Call Business Wire
Oct-07-20 12:45PM	Charles River (CRL) is an Incredible Growth Stock: 3 Reasons Why Zacks
Sep-26-20 09:51AM	How Good Is Charles River Laboratories International, Inc. (NYSE:CRL), When It Comes To ROE? Simply Wall St.
Sep-23-20 11:49AM	Western Digital Stock Spikes On Speculation It May Split Into Two Barrons.com
Sep-21-20 02:52PM	Buy Western Digital Stock, Analyst Says. Kioxias IPO Will Show Its True Valuation. Barrons.com
Sep-15-20 04:03PM	Charles River Labs Shakes Off Covid-19 Impact To Record High And Stock Of The Day Investor's Business Daily
03:11PM	Stocks Climb Broadly But Apple Quiet After It Unveils Products Investor's Business Daily
02:25PM	Charles River Labs Shakes Off Covid-19 Impact To Record High And Stock Of The Day Investor's Business Daily
11:36AM	Charles River Labs Breaks Out Investor's Business Daily Video
Sep-13-20 08:00PM	Market Digest: GNRC, AAP, CRL, LULU, RY, EXC Argus Research
08:00PM	Analyst Report: Charles River Laboratories Int Argus Research
Sep-09-20 09:35AM	Hedge Funds Have Never Been This Bullish On Charles River Laboratories (CRL) Insider Monkey
Sep-08-20 08:30AM	Charles River Laboratories to Present at September Investor Conferences Business Wire
Aug-31-20 08:59AM	How Is Charles River Laboratories International's (NYSE:CRL) CEO Paid Relative To Peers? Simply Wall St.
Aug-28-20 11:20AM	Edited Transcript of CRL.N earnings conference call or presentation 6-Nov-19 2:00pm GMT Thomson Reuters StreetEvents
Aug-07-20 02:00AM	World's First Development and Demonstration of a Quantum Cryptographic Communication Technology Applied System for Genomic Medicine PR Newswire
Aug-05-20 05:00PM	Charles River Laboratories International Inc (CRL) Q2 2020 Earnings Call Transcript Motley Fool +6.89%
09:05AM	Charles River Laboratories (CRL) Q2 Earnings and Revenues Beat Estimates Zacks
07:53AM	Charles River: Q2 Earnings Insights Benzinga
07:21AM	Charles River Laboratories International, Inc. (NYSE:CRL) Shares Could Be 34% Above Their Intrinsic Value Estimate Simply Wall St.
07:00AM	Charles River Laboratories Announces Second-Quarter 2020 Results Business Wire
Aug-04-20 05:53PM	Agilent Technologies At Upper End Of Buy Range With Earnings Due Investor's Business Daily
05:39PM	Luminex Scores Relative Strength Rating Upgrade Investor's Business Daily
09:41AM	Healthcare Stock Q2 Earnings Roster for Aug 5: HUM, CRL & More Zacks
09:07AM	Should You Buy Charles River Laboratories (CRL) Ahead of Earnings? Zacks
Jul-31-20 12:32PM	Should Investors Buy the Dip in Charles River Laboratories (CRL) Stock? Insider Monkey
Jul-29-20 12:33PM	Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Jul-24-20 07:39PM	Charles River Labs International Trading In New Buy Range With Quarterly Report On Tap Investor's Business Daily
Jul-22-20 09:19AM	Farallon plans to vote for the shareholder proposals at Toshiba's 181st Annual General Meeting PR Newswire
Jul-20-20 12:10PM	Can Charles River (CRL) Keep the Earnings Surprise Streak Alive? Zacks
Jul-15-20 04:42PM	IBD Stock Of The Day: Why This Medical Player Isn't Sweating The Pandemic Investor's Business Daily
Jul-14-20 08:30AM	Charles River Laboratories Schedules Second-Quarter 2020 Earnings Release and Conference Call Business Wire
Jul-13-20 05:03PM	Did Hedge Funds Make The Right Call On Charles River Laboratories International Inc. (CRL) ? Insider Monkey
Jul-09-20 03:24PM	The Charles River Laboratories International (NYSE:CRL) Share Price Is Up 147% And Shareholders Are Boasting About It Simply Wall St.
Jun-15-20 09:59AM	Edited Transcript of CRL earnings conference call or presentation 7-May-20 1:30pm GMT Thomson Reuters StreetEvents
Jun-11-20 10:05AM	Zacks.com featured highlights include: Lowes Companies, Charles River Laboratories International, Agilent Technologies and East West Zacks
09:02AM	Moving Average Crossover Alert: Charles River Laboratories International Zacks
Jun-10-20 10:25AM	4 GARP Stocks to Scoop Up for Maximum Returns Zacks
Jun-03-20 02:46AM	Hedge Funds Never Been This Bullish On Charles River Laboratories International (CRL) Insider Monkey
Jun-02-20 08:00AM	HemaCare Adds GMPrimeTM Cryopreserved Leukopak to its GMP Product Portfolio Business Wire
07:58AM	Charles River Laboratories' Shares March Higher, Can It Continue? Zacks
Jun-01-20 08:00AM	Charles River Laboratories to Participate in Jefferies and William Blair Conferences Business Wire
May-30-20 10:54PM	Drugs standards group nixes plan to kick pharma's crab blood habit Reuters
11:42AM	Drugs standards group nixes plan to kick pharma's crab blood habit Reuters
May-28-20 11:00AM	Shinshu University and Toshiba Develop Tumor-Tropic Liposome Technology that Carries Therapeutic Genes into Cancer Cells PR Newswire
May-21-20 07:13AM	A Rising Share Price Has Us Looking Closely At Charles River Laboratories International, Inc.'s (NYSE:CRL) P/E Ratio Simply Wall St.
May-09-20 09:12AM	At US$160, Is It Time To Put Charles River Laboratories International, Inc. (NYSE:CRL) On Your Watch List? Simply Wall St.
May-08-20 12:31AM	Charles River Laboratories International Inc (CRL) Q1 2020 Earnings Call Transcript Motley Fool
May-07-20 08:25AM	Charles River Laboratories (CRL) Q1 Earnings and Revenues Surpass Estimates Zacks +8.98%
07:00AM	Charles River Laboratories Announces First-Quarter 2020 Results Business Wire
Apr-30-20 12:34PM	Charles River Laboratories (CRL) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Apr-29-20 12:08PM	Why Horizon Kinetics is Bullish on Charles River Laboratories (CRL) Stock? Insider Monkey
Apr-20-20 03:24PM	Earnings Season Preview: Medpace Near Buy Zone With Quarterly Report Due Investor's Business Daily
Apr-19-20 03:54PM	Covid-19 Shines Spotlight on Clarivate GuruFocus.com
Apr-16-20 08:40AM	How Does Charles River Laboratories International's (NYSE:CRL) P/E Compare To Its Industry, After Its Big Share Price Gain? Simply Wall St.
08:30AM	Charles River Laboratories Schedules First-Quarter 2020 Earnings Release and Conference Call Business Wire
Mar-30-20 08:30AM	Charles River Laboratories and Deciphex Form a Partnership to Enhance Drug Discovery & Development With Digital Pathology Business Wire
Mar-25-20 06:26AM	How Does Charles River Laboratories International's (NYSE:CRL) P/E Compare To Its Industry, After The Share Price Drop? Simply Wall St. +8.38%

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains and purpose-bred rats and mice for use by researchers. It also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets and chemical compounds through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. It also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company was founded in 1947 and is based in Wilmington, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Barbo William D	Corporate Executive VP & CCO	Mar 01	Option Exercise	88.05	3,493	307,559	7,311	Mar 02 04:37 PM
Smith David Ross	Corporate Executive VP & CFO	Mar 01	Option Exercise	88.05	4,366	384,426	21,228	Mar 02 04:39 PM
MILNE GEORGE M JR	Director	Mar 01	Option Exercise	52.29	3,530	184,584	31,947	Mar 02 04:47 PM
Smith David Ross	Corporate Executive VP & CFO	Mar 01	Sale	290.12	4,366	1,266,647	16,862	Mar 02 04:39 PM
Barbo William D	Corporate Executive VP & CCO	Mar 01	Sale	290.43	1,157	336,028	16,975	Mar 02 04:37 PM
Barbo William D	Corporate Executive VP & CCO	Mar 01	Sale	290.10	3,493	1,013,312	3,818	Mar 02 04:37 PM
MILNE GEORGE M JR	Director	Mar 01	Sale	290.01	3,530	1,023,730	28,417	Mar 02 04:47 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Feb 25	Option Exercise	88.05	2,750	242,138	19,996	Feb 26 04:51 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Feb 25	Sale	281.70	8,735	2,460,615	11,261	Feb 26 04:51 PM
FOSTER JAMES C	Chairman, President and CEO	Feb 24	Option Exercise	88.05	24,009	2,113,992	245,160	Feb 25 04:23 PM
FOSTER JAMES C	Chairman, President and CEO	Feb 24	Sale	284.75	24,009	6,836,607	221,151	Feb 25 04:23 PM
FOSTER JAMES C	Chairman, President and CEO	Feb 23	Option Exercise	109.34	20,295	2,219,055	243,656	Feb 24 11:10 AM
CHUBB STEPHEN D	Director	Feb 23	Option Exercise	52.29	3,530	184,584	41,187	Feb 24 11:02 AM
CHUBB STEPHEN D	Director	Feb 23	Sale	281.66	658	185,330	40,529	Feb 24 11:02 AM
FOSTER JAMES C	Chairman, President and CEO	Feb 23	Sale	279.80	20,295	5,678,578	223,361	Feb 24 11:10 AM
FOSTER JAMES C	Chairman, President and CEO	Feb 22	Option Exercise	144.67	17,436	2,522,466	244,605	Feb 24 11:10 AM
FOSTER JAMES C	Chairman, President and CEO	Feb 22	Sale	282.98	17,436	4,934,118	227,169	Feb 24 11:10 AM
Girshick Birgit	Corporate Executive VP	Feb 19	Option Exercise	73.70	1,675	123,448	31,680	Feb 23 11:41 AM
Girshick Birgit	Corporate Executive VP	Feb 19	Sale	293.92	1,675	492,311	30,005	Feb 23 11:41 AM
Knell Michael Gunnar	CSVP&Chief Accounting Officer	Feb 19	Sale	290.99	410	119,305	4,198	Feb 23 11:32 AM
Smith David Ross	Corporate Executive VP & CFO	Feb 19	Sale	290.63	8,656	2,515,686	0	Feb 23 11:16 AM
FOSTER JAMES C	Chairman, President and CEO	Feb 11	Sale	285.02	30,000	8,550,556	227,169	Feb 16 11:58 AM
Smith David Ross	Corporate Executive VP & CFO	Jan 04	Sale	248.76	5,000	1,243,788	15,767	Jan 05 05:21 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Nov 04	Option Exercise	123.73	6,739	833,841	18,095	Nov 05 11:46 AM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Nov 04	Sale	250.28	6,739	1,686,627	11,356	Nov 05 11:46 AM
Barbo William D	Corporate Executive VP & CCO	Nov 03	Sale	236.29	2,150	508,015	9,821	Nov 05 03:51 PM
WALLMAN RICHARD F	Director	Nov 02	Buy	233.24	6,050	1,411,104	6,050	Nov 03 01:21 PM
WALLMAN RICHARD F	Director	Nov 02	Buy	232.96	1,150	267,902	31,715	Nov 03 01:21 PM
FOSTER JAMES C	Chairman, President and CEO	Nov 02	Sale	232.38	22,000	5,112,267	186,777	Nov 03 04:05 PM
MASSARO GEORGE	Director	Sep 14	Sale	219.91	1,943	427,284	9,441	Sep 15 05:47 PM
Girshick Birgit	Corporate Executive VP	Aug 20	Sale	213.51	933	199,205	22,852	Aug 21 10:48 AM
CHUBB STEPHEN D	Director	Aug 18	Sale	217.65	1,000	217,651	37,657	Aug 19 02:48 PM
Knell Michael Gunnar	CSVP&Chief Accounting Officer	Aug 07	Option Exercise	111.41	3,441	383,353	5,855	Aug 10 03:20 PM
Smith David Ross	Corporate Executive VP & CFO	Aug 07	Option Exercise	144.67	3,304	477,990	24,071	Aug 10 04:18 PM
Kochevar Deborah Turner	Director	Aug 07	Sale	216.24	2,319	501,467	6,728	Aug 11 10:39 AM
FOSTER JAMES C	Chairman, President and CEO	Aug 07	Sale	217.49	24,000	5,219,771	210,777	Aug 10 04:25 PM
Knell Michael Gunnar	CSVP&Chief Accounting Officer	Aug 07	Sale	216.60	3,456	748,555	2,399	Aug 10 03:20 PM
Smith David Ross	Corporate Executive VP & CFO	Aug 07	Sale	216.54	3,304	715,444	20,767	Aug 10 04:18 PM
MASSARO GEORGE	Director	May 22	Sale	173.40	941	163,168	11,884	May 26 02:37 PM
BERTOLINI ROBERT J	Director	May 20	Option Exercise	52.29	3,530	184,584	32,664	May 21 11:36 AM
BERTOLINI ROBERT J	Director	May 20	Sale	174.58	3,530	616,263	29,134	May 21 11:36 AM
LaPlume Joseph W	EVP, Corp Strategy & Develop	May 18	Sale	174.65	350	61,128	9,637	May 19 04:18 PM
FOSTER JAMES C	Chairman, President and CEO	May 18	Sale	175.00	17,435	3,051,125	229,894	May 19 04:14 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	May 15	Option Exercise	80.48	6,350	511,045	25,405	May 19 04:18 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	May 15	Sale	168.26	15,418	2,594,170	9,987	May 19 04:18 PM
Girshick Birgit	Corporate Executive VP	May 12	Sale	165.74	780	129,277	21,837	May 13 08:18 AM
FOSTER JAMES C	Chairman, President and CEO	May 11	Sale	162.53	17,446	2,835,433	249,329	May 13 11:02 AM
Smith David Ross	Corporate Executive VP & CFO	May 07	Sale	150.00	1,884	282,600	18,591	May 08 10:48 AM
Barbo William D	Corporate Executive VP & CCO	Mar 05	Option Exercise	102.56	12,467	1,278,677	30,201	Mar 06 03:50 PM
Barbo William D	Corporate Executive VP & CCO	Mar 05	Sale	164.35	13,966	2,295,300	16,235	Mar 06 03:50 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience